Your session is about to expire
← Back to Search
Local Anesthetic + Education for Carpal Tunnel Syndrome
Study Summary
This trial looks at reducing opioid use after carpal tunnel surgery by using a local anesthetic and more education.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You are allergic to Percocet or acetaminophen.I am older than 18 years.I am currently taking tricyclic antidepressants.I have used opioids in the last 6 months before surgery.I have been diagnosed with carpal tunnel syndrome.I am older than 18 years.People who are in prison or pregnant.You are allergic to bupivacaine.
- Group 1: Experimental Group: Exparel, no opioids
- Group 2: Control Group; Bupivacaine + opioids
- Drug Has Already Been Approved - The FDA has already approved this drug, and is just seeking more data.
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is this research endeavor still accepting participants?
"Absolutely, the information posted on clinicaltrials.gov states that this venture is actively recruiting individuals to partake in it. It was originally shared on February 15th 2019 and has since been amended at least once, lastly being edited on December 5th 2022. This trial requires 64 participants from a single medical facility."
How many participants have signed up for this clinical trial?
"Affirmative. According to the records on clinicaltrials.gov, this trial was initiated in February 15th 2019 and has been actively seeking participants since then; as of December 5th 2022, 64 individuals are required for 1 location."
Has the FDA certified any alternative pain management approaches?
"As this is a Phase 4 trial, meaning the treatment is already approved for use and there exists ample data supporting its safety, Differing pain management strategy was given an estimation of 3."
Who else is applying?
What state do they live in?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
Share this study with friends
Copy Link
Messenger